← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2001Last known activity
Feb 28, 2026
Timeline
2000s
- Jan 1, 2001
ZonMw: The Netherlands Organisation for Health Research and Development— Founded
Drugs by trial phase (200 distinct, 141 trials)
Phase 4 (72 own, 0 via acquisition)
Phase 3 (46 own, 0 via acquisition)
Phase 2 (24 own, 0 via acquisition)
Phase 1 (11 own, 0 via acquisition)
Other trials (47 own, 0 via acquisition)
Indications
Studied for
- Abdominal Pain
- Anemia, Sickle Cell
- Appendicitis
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Atrial Fibrillation
- Attention Deficit Disorder with Hyperactivity
- Bone Marrow Diseases
- Bone Neoplasms
- Borrelia Infections
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Cardiomyopathies
- Cardiovascular Diseases
- Cellulitis
- Cerebral Hemorrhage
- Cholecystolithiasis
- Cholelithiasis
- Cognitive Dysfunction
- Colitis
- Colitis, Ulcerative
- Colonic Diseases
- Colonic Diseases, Functional
- Colorectal Neoplasms
- Communicable Diseases
- Coronary Artery Disease
- Coronary Disease
- Critical Illness
- Crohn Disease
- Delirium
- Dementia
- Diverticulitis
- Dyspnea
- Eczema
- Endotoxemia
- Erysipelas
- Essential Hypertension
- Familial Primary Pulmonary Hypertension
- Fatigue
- Fatigue Syndrome, Chronic
- Febrile Neutropenia
- Fetal Growth Retardation
- Fetal Hypoxia
- Fever
- Fibrous Dysplasia of Bone
- Gallstones
- Hallucinations
- Heart Defects, Congenital
- Heart Diseases
- Heart Failure
- Hematoma
- Hematoma, Subdural
- Hematoma, Subdural, Chronic
- Hemorrhage
- Heroin Dependence
- Herpes Simplex
- Herpes Zoster
- Hip Fractures
- Hyperkinesis
- Hyperplasia
- Hypertension
- Hypoxia
- Infarction
- Infections
- Influenza, Human
- Irritable Bowel Syndrome
- Lung Diseases
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Lyme Disease
- Melanoma
- Mesothelioma
- Migraine Disorders
- Multiple Organ Failure
- Myocardial Infarction
- Myocardial Ischemia
- Myotonia
- Neoplasm Metastasis
- Neoplasms
- Neovascularization, Pathologic
- Neurofibroma
- Neurofibromatoses
- Neurofibromatosis 1
- Neutropenia
- Opioid-Related Disorders
- Osteoarthritis
- Osteoporosis
- Parkinson Disease
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Peritoneal Neoplasms
- Premature Birth
- Prostatic Neoplasms
- Psoriasis
- Pulmonary Disease, Chronic Obstructive
- Q Fever
- Recurrence
- Renal Insufficiency
- Reperfusion Injury
Recent trials (50)
- NCT07298005CollaboratorPhase 2Feb 28, 2026
- NCT07295314CollaboratorEarly Phase 1Jan 31, 2026
- NCT07295353CollaboratorN/AJan 31, 2026
- NCT07146295CollaboratorN/AApr 18, 2025
- NCT06841003CollaboratorPhase 3Feb 28, 2025
- NCT06638567CollaboratorN/ANov 1, 2024
- NCT06560164CollaboratorN/AOct 1, 2024
- NCT06578182CollaboratorPhase 3Oct 1, 2024
- NCT06452498CollaboratorPhase 3Aug 31, 2024
- NCT06306404CollaboratorPhase 4Jun 1, 2024
- NCT06240520CollaboratorPhase 1/Phase 2Apr 30, 2024
- NCT06341101CollaboratorPhase 4Mar 26, 2024
- NCT05851508CollaboratorPhase 3Oct 1, 2023
- NCT05865743CollaboratorPhase 3Sep 30, 2023
- NCT05914467CollaboratorPhase 4Aug 1, 2023
Details
- Founded
- The Hague, NL Jan 1, 2001
- Last known activity
- Feb 28, 2026